Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Yun Kyung ChoWoo Je Lee

Abstract

We aimed to evaluate the effectiveness of quadruple oral therapy in patients with inadequately controlled type 2 diabetes (T2D) with the use of three types of oral hypoglycemic agents. Medical records of 318 patients with T2D who were prescribed quadruple therapy in the Asan Medical Center were reviewed. Changes in glycated hemoglobin (HbA1c) and fasting plasma glucose (FPG) levels from baseline were assessed. The regimens of quadruple oral therapy included the following: (1) thiazolidinedione (TZD) add-on to metformin (MET) + sulfonylurea (SU) + dipeptidyl peptidase 4 inhibitor (DPP4i), (2) sodium-glucose cotransporter 2 inhibitor (SGLT2i) add-on to MET + SU + DPP4i, and (3) DPP4i add-on to MET + SU + TZD. The TZD add-on significantly reduced HbA1c levels by 1.1% (from 9.0 ± 1.1 to 7.9 ± 1.1%, P < 0.001) and FPG levels by 41.4 mg/dL (from 188.9 ± 45.9 to 147.4 ± 51.3 mg/dL, P < 0.001). The SGLT2i add-on changed the mean HbA1c level from 8.9 ± 1.0 to 7.8 ± 1.0%, a reduction of 1.1% (P < 0.001) and changed the mean FPG level from 193.4 ± 46.2 to 152.6 ± 37.0 mg/dL, a reduction of 40.8 mg/dL (P < 0.001). Finally, the DPP4i add-on reduced HbA1c levels by 1.3% (from 9.1 ± 1.3 to 7.8 ± 1.4%, P < 0.001) and FPG levels by 39.3 mg/dL (...Continue Reading

References

Jul 25, 2000·Diabetes·K F PetersenG I Shulman
Aug 14, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M Korytkowski
Aug 9, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeroen P H van WijkTon J Rabelink
Mar 12, 2009·Current Protein & Peptide Science·Filip K KnopJens J Holst
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Feb 9, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotP-M Schumm-Draeger
Jan 1, 2012·Journal of Community Hospital Internal Medicine Perspectives·Celeste C L Quianzon, Issam E Cheikh
Nov 27, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay Kalra
Aug 5, 2017·Diabetologia·Clifford J Bailey
Oct 17, 2017·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Mirko V SikiricaVictoria Higgins
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Feb 1, 2019·Drugs·Maria J Pereira, Jan W Eriksson
Jul 25, 2019·Diabetes & Metabolic Syndrome·Habib YaribeygiAmirhossein Sahebkar

❮ Previous
Next ❯

Citations

May 4, 2021·American Journal of Physiology. Endocrinology and Metabolism·Vivien ChavanellePascal Sirvent

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies

Software Mentioned

Statistical Package for the Social Sciences ( SPSS )

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.